Pharmaceutical

AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use

The twice daily tablet represents a significant step forward for patients with advanced breast cancer.

Apr 12, 2025 - 06:00
AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use
The twice daily tablet represents a significant step forward for patients with advanced breast cancer.
Read the original article

Tags:

Previous Article

FDA to phase out animal testing with AI and lab-based models

Next Article

NMPA approves BBM and Takeda China’s haemophilia B therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The evolving presence of AI in telemedicine for behavioural health

The evolving presence of AI in telemedicine for behavio...

Jan 17, 2024

STAT+: After four patients died of gene therapy, Astellas sees possible explanation — and a way forward

STAT+: After four patients died of gene therapy, Astell...

Nov 15, 2023

EMA’s CHMP recommends Bristol Myers Squibb’s Breyanzi approval

EMA’s CHMP recommends Bristol Myers Squibb’s Breyanzi a...

Apr 3, 2023